You are using an older browser version. Please use a supported version for the best MSN experience.

Johnson & Johnson in early talks to buy drugmaker Actelion

Associated Press Associated Press 25/11/2016
FILE - This Thursday, Feb 22, 2007, file photo, shows the headquarters of biopharmaceutical company Actelion, in Allschwil, Switzerland. On Friday, Nov. 25, 2016, Johnson & Johnson said it is in early talks to buy Swiss drugmaker Actelion Pharmaceuticals Ltd. Both companies said there is no certainty that a deal will happen. (Georgios Kefalas/Keystone via AP) © The Associated Press FILE - This Thursday, Feb 22, 2007, file photo, shows the headquarters of biopharmaceutical company Actelion, in Allschwil, Switzerland. On Friday, Nov. 25, 2016, Johnson & Johnson said it is in early talks to buy Swiss drugmaker Actelion Pharmaceuticals Ltd. Both companies said there is no certainty that a deal will happen. (Georgios Kefalas/Keystone via AP)

NEW YORK — Johnson & Johnson said Friday that is in early talks to buy the Swiss drugmaker Actelion Pharmaceuticals.

Actelion Pharmaceuticals Ltd. makes high blood pressure medicines that treat arteries in the lung and around the heart. Johnson & Johnson of New Brunswick, New Jersey, develops drugs and manufactures medical devices and other consumer products.

Shares of Johnson & Johnson rose $1.06 to $114.13 Friday.

image beaconimage beaconimage beacon